Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer
- 1 February 1989
- journal article
- conference paper
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 28 (2) , 143-147
- https://doi.org/10.1007/bf00199115
Abstract
Characterization of T-lymphocyte subpopulations adjacent to and infiltrating the primary tumor of breast cancer was carried out using a direct immunofluorescence procedure with the antibodies anti-(Leu-2a) for suppressor/cytotoxic (CD8+) and anti-(Leu-3a) for helper/inducer (CD4+) T-lymphocytes. Fifty-six primary malignant tumors with lymphoid infiltration were studied. The majority (58.9%) were infiltrating duct carcinoma. There were metastases to axillary lymph nodes in 6.67% of the patients. Massive lymphoid infiltration (>40 lymphocytes per ×400 microscopic field) was found in 19.6% of the tumors and moderate infiltration (20–40 lymphocytes per field) in 51.8%. In all the tumors studied there was a reversed CD4+/CD8+ ratio as compared to that found in normal peripheral blood. In 66.1% the CD4+/CD8+ ratio (helper/suppressor) was less than 1.0. The reversed ratio was due to a significant decrease in the number of helper cells (PPP=0.001). Of particular interest was the significant positive correlation between the age of the patients and an increased number of CD4+lymphocytes in the stroma (P=0.02). Significant negative correlations were found between a reduced number of CD4+ lymphocytes or CD4+/CD8+ ratio and several histological parameters: tumor diameter, pleomorphism, nucleus/cytoplasm ratio. There was also a significant positive correlation between the total number of CD8+ lymphocytes infiltrating the tumor tissue and the number of axillary lymph nodes with metastatic disease (P=0.03). It is suggested that the reversed ratio of CD4+/CD8+ lymphocytes may significantly affect the host/tumor immune surveillance.Keywords
This publication has 26 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Immunological studies of homosexual men with immunodeficiency and Kaposi's sarcomaClinical Immunology and Immunopathology, 1983
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man.The Journal of Experimental Medicine, 1981
- Suppressor cell activity of lymphocytes infiltrating human lung and breast tumoursInternational Journal of Cancer, 1979
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen.The Journal of Experimental Medicine, 1975
- Immunological Rebound after Cessation of Long-term Chemotherapy in Acute Lymphocytic Leukaemia: Changes in Distribution of T and B Cell Populations in Bone Marrow and Peripheral BloodBritish Journal of Haematology, 1974
- Some international differences in histology and survival in breast cancerInternational Journal of Cancer, 1973
- REDUCED LYMPHOCYTE TRANSFORMATION IN BREAST CANCERThe Lancet, 1971